Myocardial sympathetic denervation prevents chamber-specific alteration of beta-adrenergic transmembrane signaling in rabbits with heart failure

Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

OBJECTIVES: The purpose of this study was to assess the effect of myocardial sympathetic denervation on the chamber-specific alteration of beta-adrenergic signaling in left ventricular failure in rabbits. BACKGROUND: Local abnormalities in sympathetic nerve terminals, including the neuronal reuptake of norepinephrine, are thought to be responsible for the chamber-specific regulation of beta-adrenergic signaling in heart failure. METHODS: Sixteen rabbits were given 6-hydroxydopamine, 25 mg/kg body weight intravenously on days 1 and 2 and 50 mg/kg intravenously on days 7 and 8. Another 16 rabbits received vehicle. Aortic regurgitation was induced in eight of the 6-hydroxydopamine-treated and eight of the vehicle-treated rabbits on day 14. Another eight of the 6-hydroxydopamine-treated and eight of the vehicle-treated rabbits underwent a sham operation. The hearts were excised for biochemical analysis on day 21. RESULTS: Hemodynamic characteristics on day 21 showed left ventricular failure in both the aortic regurgitation groups. The plasma norepinephrine concentration on day 21 was higher in both the aortic regurgitation groups than in the sham groups. The beta-adrenoceptor densities and isoproterenol plus 5'-guanylylimidodiphosphate-, 5'-guanylylimidodiphosphate- and sodium fluoride-stimulated adenylyl cyclase activities were decreased only in the failing left ventricle of the vehicle-pretreated aortic regurgitation group, but in both ventricles of the 6-hydroxydopamine-pretreated aortic regurgitation group. The basal and forskolin-stimulated adenylyl cyclase activities were similar in both the aortic regurgitation groups and in the sham groups. CONCLUSIONS: Sympathetic denervation prevented chamber-specific alterations in beta-adrenergic signaling in acute left ventricular failure. Local loss of sympathetic nerve endings, and especially the defective neuronal norepinephrine reuptake, are likely to be responsible for the chamber-specific alteration of the beta-adrenoceptor-G protein-adenylyl cyclase system in heart failure in rabbits.

This article has been cited by other articles:

				E. Plante, D. Lachance, S. Champetier, M.-C. Drolet, E. Roussel, M. Arsenault, and J. Couet Benefits of long-term {beta}-blockade in experimental chronic aortic regurgitation Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1888 - H1895. [Abstract] [Full Text] [PDF]

				E. Plante, D. Lachance, M. Gaudreau, M.-C. Drolet, E. Roussel, M. Arsenault, and J. Couet Effectiveness of {beta}-Blockade in Experimental Chronic Aortic Regurgitation Circulation, September 14, 2004; 110(11): 1477 - 1483. [Abstract] [Full Text] [PDF]

				C.-S. Liang, Y. Himura, M. Kashiki, and S. Y. Stevens Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1863 - H1872. [Abstract] [Full Text] [PDF]

				A. Baba, T. Yoshikawa, and S. Ogawa Autoantibodies produced against sarcolemmal Na-K-ATPase: possible upstream targets of arrhythmias and sudden death in patients with dilated cardiomyopathy J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1153 - 1159. [Abstract] [Full Text] [PDF]

				M. Iwata, T. Yoshikawa, A. Baba, T. Anzai, I. Nakamura, Y. Wainai, T. Takahashi, and S. Ogawa Autoimmunity Against the Second Extracellular Loop of {beta}1-Adrenergic Receptors Induces {beta}-Adrenergic Receptor Desensitization and Myocardial Hypertrophy In Vivo Circ. Res., March 30, 2001; 88(6): 578 - 586. [Abstract] [Full Text] [PDF]

				M. Bohm, M. Castellano, M. Flesch, C. Maack, M. Moll, M. Paul, F. Schiffer, and O. Zolk Chamber-Specific Alterations of Norepinephrine Uptake Sites in Cardiac Hypertrophy Hypertension, November 1, 1998; 32(5): 831 - 837. [Abstract] [Full Text] [PDF]